IL6 and neoplasm: The STAT-3 signaling pathway was also found to play a key role in meditating the effect of IL-6 on promoting tumor progression and treatment resistance by inhibiting cancer cell apoptosis and stimulating tumor-associated factors among various signaling pathways [20, 23].